HEXO to Present at Benzinga Cannabis Capital Conference in New York City on October 15
10/13/2021 - 06:30 AM
OTTAWA, Oct. 13, 2021 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO" or the "Company") (NASDAQ: HEXO) (TSX: HEXO) today announced the Company will participate in the Benzinga Cannabis Capital Conference to be hosted live in New York City, as well as virtually, on October 15, 2021. As part of the conference, HEXO’s CFO, Trent MacDonald, will present on Friday, October 15, 2021 at 1:30 p.m. ET, as well as participate in the panel “Turning Focused Growth Strategies Into Expanded Market Share” at 4:25 p.m. ET.
A live webcast link of Mr. MacDonald’s presentation and panel will be available on the investor events page of HEXO’s corporate website.
Institutional investors wishing to schedule a one-on-one meeting should contact Jennifer Smith at invest@hexo.com .
About HEXO
HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Namaste Original Stash, 48North, Trail Mix, Bake Sale, REUP and Latitude brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint-venture with Molson Coors. With the completion of HEXO’s recent acquisitions of Redecan and 48North, HEXO is a leading cannabis products company in Canada by recreational market share. For more information, please visit www.hexocorp.com.
Investor Relations: invest@HEXO.com www.hexocorp.com
Media Relations: media@hexo.com
HEXO Rankings
N/A Ranked by Stock Gains
HEXO Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Pharmaceuticals: Other, Health Technology, Process Industries, Agricultural Commodities/Milling, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
Canada
City
Ottawa
About HEXO
hydropothecary est un producteur agréé et distributeur de marijuana médicale en vertu du règlement sur l'accès aux cannabis pour fins médicales (racfm) de santé canada. nous sommes voués à l’excellence médicale et excellons dans nos techniques de culture, les contrôles des processus, les tests d’assurance-qualité, les activités de recherche et développement et l’offre d’un service à la clientèle exceptionnel. nous sommes fiers de la croissance remarquable de notre entreprise jusqu’à présent et anticipons grandement la continuation de cette expansion avec l’ajout d’une serre de 250 000 pieds carrés supplémentaires en 2018. nous sommes constamment à la recherche de professionnels talentueux, énergiques et hautement spécialisés pour joindre notre équipe et faire partie d'une industrie passionnante en évolution continue. ------------ the hydropothecary is a licensed producer and distributor of medical marijuana under health canada’s access to cannabis for medical purposes regulations (acmp
